Last 13,700 KRW
Change Today +400.00 / 3.01%
Volume 79.1K
083790 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:12 AM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul Kim

Former Executive Officer, CrystalGenomics, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Mr. Paul Kim serves as the Head of Novartis Korea Venture Fund (NKVF) - first global pharmaceutical fund to focus solely on emerging Korean biotech investments. Mr. Kim serves as a Vice President of Business Development of ViroMed and overseeing ViroMed 's corporate development & partnering activities. He served as an Executive Officer of Crystalgenomicsis Inc. Prior to ViroMed, he also served as a Vice President of Business Development at CrystalGenomics, forging key ...

Read Full Background

Corporate Headquarters*

Tower A, Korea Bio Park
Seongnam, Gyeonggi-do 463-400

South Korea

Phone: 82 3 1628 2700
Fax: 82 3 1628 2701

Board Members Memberships*

Director

Education*

Unknown/Other Education
University of California Berkeley
Bachelor's Degree
University of California Berkeley

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
083790:KS 13,700.00 KRW +400.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CRYSTALGENOMICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.